Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Final Results from the Phase 3 Traial Areta Comparing a Novel, Extended-Release Anagrelide Formulation to Placebo in Essential Thrombocythemia Patients with Defined Risk Status

Heinz Gisslinger, MD, Christoph Klade, Kudrat Abdulkadyrov, MD, Slawomira Kyrcz-Krzemien, MD PhD, Elena Karyagina, MD, Anait L. Melikyan, MD PhD, Krzysztof Warzocha, Barbara Grohmann-Izay, MD, Juri Hodisch, MD, Rudolf S. Widmann, PhD BSc, Robert Kralovics, Petro E. Petrides, MD PhD, Jiri Schwarz, MD PhD, Jean-Jacques Kiladjian, MD PhD

Blood (2016) 128 (22): 476.

https://doi.org/10.1182/blood.V128.22.476.476

Published: 2016

Journal Articles

Hematopoietic Cell Transplantation after TBI, Fludarabine, Idarubicine and Cytarabine Myeloablative Conditioning in Patients with Acute Myeloid Leukemia

Jan Vydra, MD, Veronika Válková, MD, Markéta ťastná Marková, MD, Ludmila Nováková, MD, Jiří Schwarz, MD PhD, Cyril álek, MD PhD, Antonín Vítek, MD, Petr Cetkovský, MD PhD Prof., Jaroslav Čermák, MD PhD, Kyra Michalová, Prof.

Blood (2014) 124 (21): 5847.

https://doi.org/10.1182/blood.V124.21.5847.5847

Published: 2014

Journal Articles

DNMT3A Mutations Are Connected with Lower DNA Methylation Levels and Numbers of Concurrently Hypermethylated Genes in AML Patients

Hana Hajkova, Jana Markova, Cedrik Haskovec, PhD, Jaroslav Cermak, Radka Petrbokova, Kyra Michalova, PhD, Jiri Schwarz, MD, PhD

Blood (2011) 118 (21): 4629.

https://doi.org/10.1182/blood.V118.21.4629.4629

Published: 2011

Journal Articles

Thrombosis in MPN with Thrombocythemia Is Associated with Higher Platelet Count At the Time of the Event: Data From the Czech Registry of Patients Treated with Anagrelide,

Jiri Schwarz, MD, PhD, Miroslav Penka, MD, PhD, Petra Ovesna, PhD, Olga Cerna, MD, Yvona Brychtova, MD, Petr Dulicek, MD, PhD

Blood (2011) 118 (21): 3857.

https://doi.org/10.1182/blood.V118.21.3857.3857

Published: 2011

Journal Articles

Interlaboratory Quality Control Round of MPL Mutation Detection in Fourteen European Laboratories: A MPN&MPNr-EuroNet Study,

Naomi A. Porret, PhD, Elisabeth Oppliger Leibundgut, PharmD, Serge Carillo, Bruno Cassinat, PharmD, Francois Girodon, MD, PhD, Éric Lippert, MD, PhD, Valérie Ugo, MD, PhD, Sylvie Hermouet, MD, PhD, Paola Guglielmelli, MD, Jiri Schwarz, MD, PhD, Beatriz Bellosillo, Susanne Schnittger, PhD, Maj K. Westman, Stephane Giraudier, MD, PhD

Blood (2011) 118 (21): 3859.

https://doi.org/10.1182/blood.V118.21.3859.3859

Published: 2011

Journal Articles

Expression Pattern of WT1 Isoforms in Patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) and Severe Aplastic Anemia (SAA)

Karolina Kramarzova, Andre Willasch, Bernd Gruhn, Jiri Schwarz, MD, PhD, Jana Markova, Jan Stary, M.D., Jan Trka, MD, PhD, Ludmila Boublikova

Blood (2011) 118 (21): 2502.

https://doi.org/10.1182/blood.V118.21.2502.2502

Published: 2011

Journal Articles

Improving Survival in Patients with Chronic Lymphocytic Leukemia - Population Based Study

Marek Trneny, Petra Obrtlikova, MD, PhD, Jiri Schwarz, MD, PhD, Tomas Pavlik, Jan Muzik, MSci, PhD, Ladislav Dusek, MSci, PhD

Blood (2011) 118 (21): 2852.

https://doi.org/10.1182/blood.V118.21.2852.2852

Published: 2011

Journal Articles

First Achievements of MPN&MPNr-EuroNet (COST Action BM0902), a New European Network Dedicated to the Diagnosis of Myeloproliferative Neoplasms and Hereditary Erythrocytosis and Thrombocytosis

Sylvie Hermouet, MD, PhD, Eric Lippert, PhD, Niels Pallisgaard, Jiri Schwarz, MD, PhD, Mary Frances McMullin, MD, Lars Palmqvist, MD, PhD, Heike L Pahl, Ph.D., Beatriz Bellosillo Paricio, Celeste Bento, Serge Carillo, Stephane Giraudier, MD, PhD, Francois Girodon, MD, PhD, Melanie Percy, PhD, FRCPath, Lukas Plank, Susanne Schnittger, PhD, Radek C. Skoda, MD, Alessandro M. Vannucchi, MD

Blood (2011) 118 (21): 2809.

https://doi.org/10.1182/blood.V118.21.2809.2809

Published: 2011

Journal Articles

Molecular Variability of FLT3/ITD Mutants and Their Impact on the Differentiation Program of 32D Cells: Implications for the Biological Properties of AML Blasts

Sona Pekova, M.D., PhD., Michal Dvorak, PhD., Robert Ivanek, Sabrina Rueggeberg, Stefan Leicht, Tomas Kozak, MD, PhD, Jiri Vrba, MD., Jiri Schwarz, MD., PHD., Petr Cetkovsky, MD., PHD., Miroslav Prucha, MD., PHD., Ondrej Hrusak

Blood (2008) 112 (11): 4480.

https://doi.org/10.1182/blood.V112.11.4480.4480

Published: 2008

Journal Articles

Rituximab, Fludarabin and Cyclophosphamide Followed by High Dose Therapy with Autologous Stem Cell Rescue Leads to High Molecular Remission Rate in Chronic Lymphocytic Leukemia patients but Relapses Are Observed.

Marek Trneny, MD, PhD, Jana Salkova, MD, Josef Karban, MD, Jan Cerny, MD, Kyra Michalova, MD, Jan Stritesky, MD, Jiri Schwarz, MD, PhD, Robert Pytlik, MD, Alena Slavickova, MD, PhD

Blood (2004) 104 (11): 3480.

https://doi.org/10.1182/blood.V104.11.3480.3480

Published: 2004

NARROW

Final Results from the Phase 3 Traial Areta Comparing a Novel, Extended-Release Anagrelide Formulation to Placebo in Essential Thrombocythemia Patients with Defined Risk Status

Hematopoietic Cell Transplantation after TBI, Fludarabine, Idarubicine and Cytarabine Myeloablative Conditioning in Patients with Acute Myeloid Leukemia

DNMT3A Mutations Are Connected with Lower DNA Methylation Levels and Numbers of Concurrently Hypermethylated Genes in AML Patients

Thrombosis in MPN with Thrombocythemia Is Associated with Higher Platelet Count At the Time of the Event: Data From the Czech Registry of Patients Treated with Anagrelide,

Interlaboratory Quality Control Round of MPL Mutation Detection in Fourteen European Laboratories: A MPN&MPNr-EuroNet Study,

Expression Pattern of WT1 Isoforms in Patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) and Severe Aplastic Anemia (SAA)

Improving Survival in Patients with Chronic Lymphocytic Leukemia - Population Based Study

First Achievements of MPN&MPNr-EuroNet (COST Action BM0902), a New European Network Dedicated to the Diagnosis of Myeloproliferative Neoplasms and Hereditary Erythrocytosis and Thrombocytosis

Molecular Variability of FLT3/ITD Mutants and Their Impact on the Differentiation Program of 32D Cells: Implications for the Biological Properties of AML Blasts

Rituximab, Fludarabin and Cyclophosphamide Followed by High Dose Therapy with Autologous Stem Cell Rescue Leads to High Molecular Remission Rate in Chronic Lymphocytic Leukemia patients but Relapses Are Observed.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only